They have been positioning themselves to move entirely to the LSE for ages. I suspect they will not be able to stay on the ASX for too much longer - and, to be honest, they have no reason for being on the ASX as they have no business footprint in Australia.
Plus, not many gullible shareholders left in Australia.
Ann: Argent BioPharma Appointments UK Corporate Broker, page-2
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
55.0¢ |
Change
-0.015(2.65%) |
Mkt cap ! $26.62M | |||
| Open | High | Low | Value | Volume |
| 56.5¢ | 56.5¢ | 55.0¢ | $2.105K | 3.789K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4959 | 50.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 57.0¢ | 2662 | 2 |
View Market Depth
| Last trade - 11.12am 09/10/2024 (20 minute delay) ? |
| RGT (ASX) Chart |